Global Urological Cancer Therapeutics Drugs Market Professional Survey Report 2018

January 2018 | 113 pages | ID: G5D52CFF2EBEN
QYResearch

Abstracts

This report studies Urological Cancer Therapeutics Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Novartis
• Pfizer
• Johnson & Johnson
• AstraZeneca
• Astellas
• Bristol-Myers Squibb
• Abbott Laboratories
• Celgene Corporation
• Dendreon Corporation
• Ferring Pharmaceuticals
• GlaxoSmithKline plc
• Indevus Pharmaceuticals Inc
• Ipsen
• Roche Healthcare
• Sanofi S.A.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Xofigo (radium Ra 223 dichloride)
• Jevtana (cabazitaxel)
• Inlyta (axitinib)
• Votrient (pazopanib hydrochloride)
• Sutent (sunitinib malate)
• Zytiga (abiraterone acetate)
• Xtandi (enzalutamide)
• Opdivo (nivolumab)
• Provenge (sipuleucel-T)

By Application, the market can be split into

• Hospital
• Medical Research Laboratory
• Others

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Urological Cancer Therapeutics Drugs Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF UROLOGICAL CANCER THERAPEUTICS DRUGS

1.1 Definition and Specifications of Urological Cancer Therapeutics Drugs
  1.1.1 Definition of Urological Cancer Therapeutics Drugs
  1.1.2 Specifications of Urological Cancer Therapeutics Drugs
1.2 Classification of Urological Cancer Therapeutics Drugs
  1.2.1 Xofigo (radium Ra 223 dichloride)
  1.2.2 Jevtana (cabazitaxel)
  1.2.3 Inlyta (axitinib)
  1.2.4 Votrient (pazopanib hydrochloride)
  1.2.5 Sutent (sunitinib malate)
  1.2.6 Zytiga (abiraterone acetate)
  1.2.7 Xtandi (enzalutamide)
  1.2.8 Opdivo (nivolumab)
  1.2.9 Provenge (sipuleucel-T)
1.3 Applications of Urological Cancer Therapeutics Drugs
  1.3.1 Hospital
  1.3.2 Medical Research Laboratory
  1.3.3 Others
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF UROLOGICAL CANCER THERAPEUTICS DRUGS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Urological Cancer Therapeutics Drugs
2.3 Manufacturing Process Analysis of Urological Cancer Therapeutics Drugs
2.4 Industry Chain Structure of Urological Cancer Therapeutics Drugs

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF UROLOGICAL CANCER THERAPEUTICS DRUGS

3.1 Capacity and Commercial Production Date of Global Urological Cancer Therapeutics Drugs Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Urological Cancer Therapeutics Drugs Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Urological Cancer Therapeutics Drugs Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Urological Cancer Therapeutics Drugs Major Manufacturers in 2016

4 GLOBAL UROLOGICAL CANCER THERAPEUTICS DRUGS OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Urological Cancer Therapeutics Drugs Capacity and Growth Rate Analysis
  4.2.2 2016 Urological Cancer Therapeutics Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Urological Cancer Therapeutics Drugs Sales and Growth Rate Analysis
  4.3.2 2016 Urological Cancer Therapeutics Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Urological Cancer Therapeutics Drugs Sales Price
  4.4.2 2016 Urological Cancer Therapeutics Drugs Sales Price Analysis (Company Segment)

5 UROLOGICAL CANCER THERAPEUTICS DRUGS REGIONAL MARKET ANALYSIS

5.1 North America Urological Cancer Therapeutics Drugs Market Analysis
  5.1.1 North America Urological Cancer Therapeutics Drugs Market Overview
  5.1.2 North America 2012-2017E Urological Cancer Therapeutics Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Urological Cancer Therapeutics Drugs Sales Price Analysis
  5.1.4 North America 2016 Urological Cancer Therapeutics Drugs Market Share Analysis
5.2 China Urological Cancer Therapeutics Drugs Market Analysis
  5.2.1 China Urological Cancer Therapeutics Drugs Market Overview
  5.2.2 China 2012-2017E Urological Cancer Therapeutics Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Urological Cancer Therapeutics Drugs Sales Price Analysis
  5.2.4 China 2016 Urological Cancer Therapeutics Drugs Market Share Analysis
5.3 Europe Urological Cancer Therapeutics Drugs Market Analysis
  5.3.1 Europe Urological Cancer Therapeutics Drugs Market Overview
  5.3.2 Europe 2012-2017E Urological Cancer Therapeutics Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Urological Cancer Therapeutics Drugs Sales Price Analysis
  5.3.4 Europe 2016 Urological Cancer Therapeutics Drugs Market Share Analysis
5.4 Southeast Asia Urological Cancer Therapeutics Drugs Market Analysis
  5.4.1 Southeast Asia Urological Cancer Therapeutics Drugs Market Overview
  5.4.2 Southeast Asia 2012-2017E Urological Cancer Therapeutics Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Urological Cancer Therapeutics Drugs Sales Price Analysis
  5.4.4 Southeast Asia 2016 Urological Cancer Therapeutics Drugs Market Share Analysis
5.5 Japan Urological Cancer Therapeutics Drugs Market Analysis
  5.5.1 Japan Urological Cancer Therapeutics Drugs Market Overview
  5.5.2 Japan 2012-2017E Urological Cancer Therapeutics Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Urological Cancer Therapeutics Drugs Sales Price Analysis
  5.5.4 Japan 2016 Urological Cancer Therapeutics Drugs Market Share Analysis
5.6 India Urological Cancer Therapeutics Drugs Market Analysis
  5.6.1 India Urological Cancer Therapeutics Drugs Market Overview
  5.6.2 India 2012-2017E Urological Cancer Therapeutics Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Urological Cancer Therapeutics Drugs Sales Price Analysis
  5.6.4 India 2016 Urological Cancer Therapeutics Drugs Market Share Analysis

6 GLOBAL 2012-2017E UROLOGICAL CANCER THERAPEUTICS DRUGS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Urological Cancer Therapeutics Drugs Sales by Type
6.2 Different Types of Urological Cancer Therapeutics Drugs Product Interview Price Analysis
6.3 Different Types of Urological Cancer Therapeutics Drugs Product Driving Factors Analysis
  6.3.1 Xofigo (radium Ra 223 dichloride) of Urological Cancer Therapeutics Drugs Growth Driving Factor Analysis
  6.3.2 Jevtana (cabazitaxel) of Urological Cancer Therapeutics Drugs Growth Driving Factor Analysis
  6.3.3 Inlyta (axitinib) of Urological Cancer Therapeutics Drugs Growth Driving Factor Analysis
  6.3.4 Votrient (pazopanib hydrochloride) of Urological Cancer Therapeutics Drugs Growth Driving Factor Analysis
  6.3.5 Sutent (sunitinib malate) of Urological Cancer Therapeutics Drugs Growth Driving Factor Analysis
  6.3.6 Zytiga (abiraterone acetate) of Urological Cancer Therapeutics Drugs Growth Driving Factor Analysis
  6.3.7 Xtandi (enzalutamide) of Urological Cancer Therapeutics Drugs Growth Driving Factor Analysis
  6.3.8 Opdivo (nivolumab) of Urological Cancer Therapeutics Drugs Growth Driving Factor Analysis
  6.3.9 Provenge (sipuleucel-T) of Urological Cancer Therapeutics Drugs Growth Driving Factor Analysis

7 GLOBAL 2012-2017E UROLOGICAL CANCER THERAPEUTICS DRUGS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Urological Cancer Therapeutics Drugs Consumption by Application
7.2 Different Application of Urological Cancer Therapeutics Drugs Product Interview Price Analysis
7.3 Different Application of Urological Cancer Therapeutics Drugs Product Driving Factors Analysis
  7.3.1 Hospital of Urological Cancer Therapeutics Drugs Growth Driving Factor Analysis
  7.3.2 Medical Research Laboratory of Urological Cancer Therapeutics Drugs Growth Driving Factor Analysis
  7.3.3 Others of Urological Cancer Therapeutics Drugs Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF UROLOGICAL CANCER THERAPEUTICS DRUGS

8.1 Novartis
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Novartis 2016 Urological Cancer Therapeutics Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Novartis 2016 Urological Cancer Therapeutics Drugs Business Region Distribution Analysis
8.2 Pfizer
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Pfizer 2016 Urological Cancer Therapeutics Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Pfizer 2016 Urological Cancer Therapeutics Drugs Business Region Distribution Analysis
8.3 Johnson & Johnson
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Johnson & Johnson 2016 Urological Cancer Therapeutics Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Johnson & Johnson 2016 Urological Cancer Therapeutics Drugs Business Region Distribution Analysis
8.4 AstraZeneca
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 AstraZeneca 2016 Urological Cancer Therapeutics Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 AstraZeneca 2016 Urological Cancer Therapeutics Drugs Business Region Distribution Analysis
8.5 Astellas
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Astellas 2016 Urological Cancer Therapeutics Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Astellas 2016 Urological Cancer Therapeutics Drugs Business Region Distribution Analysis
8.6 Bristol-Myers Squibb
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Bristol-Myers Squibb 2016 Urological Cancer Therapeutics Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Bristol-Myers Squibb 2016 Urological Cancer Therapeutics Drugs Business Region Distribution Analysis
8.7 Abbott Laboratories
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Abbott Laboratories 2016 Urological Cancer Therapeutics Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Abbott Laboratories 2016 Urological Cancer Therapeutics Drugs Business Region Distribution Analysis
8.8 Celgene Corporation
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Celgene Corporation 2016 Urological Cancer Therapeutics Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Celgene Corporation 2016 Urological Cancer Therapeutics Drugs Business Region Distribution Analysis
8.9 Dendreon Corporation
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Dendreon Corporation 2016 Urological Cancer Therapeutics Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Dendreon Corporation 2016 Urological Cancer Therapeutics Drugs Business Region Distribution Analysis
8.10 Ferring Pharmaceuticals
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Ferring Pharmaceuticals 2016 Urological Cancer Therapeutics Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Ferring Pharmaceuticals 2016 Urological Cancer Therapeutics Drugs Business Region Distribution Analysis
8.11 GlaxoSmithKline plc
8.12 Indevus Pharmaceuticals Inc
8.13 Ipsen
8.14 Roche Healthcare
8.15 Sanofi S.A.

9 DEVELOPMENT TREND OF ANALYSIS OF UROLOGICAL CANCER THERAPEUTICS DRUGS MARKET

9.1 Global Urological Cancer Therapeutics Drugs Market Trend Analysis
  9.1.1 Global 2017-2022 Urological Cancer Therapeutics Drugs Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Urological Cancer Therapeutics Drugs Sales Price Forecast
9.2 Urological Cancer Therapeutics Drugs Regional Market Trend
  9.2.1 North America 2017-2022 Urological Cancer Therapeutics Drugs Consumption Forecast
  9.2.2 China 2017-2022 Urological Cancer Therapeutics Drugs Consumption Forecast
  9.2.3 Europe 2017-2022 Urological Cancer Therapeutics Drugs Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Urological Cancer Therapeutics Drugs Consumption Forecast
  9.2.5 Japan 2017-2022 Urological Cancer Therapeutics Drugs Consumption Forecast
  9.2.6 India 2017-2022 Urological Cancer Therapeutics Drugs Consumption Forecast
9.3 Urological Cancer Therapeutics Drugs Market Trend (Product Type)
9.4 Urological Cancer Therapeutics Drugs Market Trend (Application)

10 UROLOGICAL CANCER THERAPEUTICS DRUGS MARKETING TYPE ANALYSIS

10.1 Urological Cancer Therapeutics Drugs Regional Marketing Type Analysis
10.2 Urological Cancer Therapeutics Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Urological Cancer Therapeutics Drugs by Region
10.4 Urological Cancer Therapeutics Drugs Supply Chain Analysis

11 CONSUMERS ANALYSIS OF UROLOGICAL CANCER THERAPEUTICS DRUGS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL UROLOGICAL CANCER THERAPEUTICS DRUGS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Urological Cancer Therapeutics Drugs
Table Product Specifications of Urological Cancer Therapeutics Drugs
Table Classification of Urological Cancer Therapeutics Drugs
Figure Global Production Market Share of Urological Cancer Therapeutics Drugs by Type in 2016
Figure Xofigo (radium Ra 223 dichloride) Picture
Table Major Manufacturers of Xofigo (radium Ra 223 dichloride)
Figure Jevtana (cabazitaxel) Picture
Table Major Manufacturers of Jevtana (cabazitaxel)
Figure Inlyta (axitinib) Picture
Table Major Manufacturers of Inlyta (axitinib)
Figure Votrient (pazopanib hydrochloride) Picture
Table Major Manufacturers of Votrient (pazopanib hydrochloride)
Figure Sutent (sunitinib malate) Picture
Table Major Manufacturers of Sutent (sunitinib malate)
Figure Zytiga (abiraterone acetate) Picture
Table Major Manufacturers of Zytiga (abiraterone acetate)
Figure Xtandi (enzalutamide) Picture
Table Major Manufacturers of Xtandi (enzalutamide)
Figure Opdivo (nivolumab) Picture
Table Major Manufacturers of Opdivo (nivolumab)
Figure Provenge (sipuleucel-T) Picture
Table Major Manufacturers of Provenge (sipuleucel-T)
Table Applications of Urological Cancer Therapeutics Drugs
Figure Global Consumption Volume Market Share of Urological Cancer Therapeutics Drugs by Application in 2016
Figure Hospital Examples
Table Major Consumers in Hospital
Figure Medical Research Laboratory Examples
Table Major Consumers in Medical Research Laboratory
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Urological Cancer Therapeutics Drugs by Regions
Figure North America Urological Cancer Therapeutics Drugs Market Size (Million USD) (2012-2022)
Figure China Urological Cancer Therapeutics Drugs Market Size (Million USD) (2012-2022)
Figure Europe Urological Cancer Therapeutics Drugs Market Size (Million USD) (2012-2022)
Figure Southeast Asia Urological Cancer Therapeutics Drugs Market Size (Million USD) (2012-2022)
Figure Japan Urological Cancer Therapeutics Drugs Market Size (Million USD) (2012-2022)
Figure India Urological Cancer Therapeutics Drugs Market Size (Million USD) (2012-2022)
Table Urological Cancer Therapeutics Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Urological Cancer Therapeutics Drugs in 2016
Figure Manufacturing Process Analysis of Urological Cancer Therapeutics Drugs
Figure Industry Chain Structure of Urological Cancer Therapeutics Drugs
Table Capacity and Commercial Production Date of Global Urological Cancer Therapeutics Drugs Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Urological Cancer Therapeutics Drugs Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Urological Cancer Therapeutics Drugs Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Urological Cancer Therapeutics Drugs Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Urological Cancer Therapeutics Drugs 2012-2017
Figure Global 2012-2017E Urological Cancer Therapeutics Drugs Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Urological Cancer Therapeutics Drugs Market Size (Value) and Growth Rate
Table 2012-2017E Global Urological Cancer Therapeutics Drugs Capacity and Growth Rate
Table 2016 Global Urological Cancer Therapeutics Drugs Capacity (Units) List (Company Segment)
Table 2012-2017E Global Urological Cancer Therapeutics Drugs Sales (Units) and Growth Rate
Table 2016 Global Urological Cancer Therapeutics Drugs Sales (Units) List (Company Segment)
Table 2012-2017E Global Urological Cancer Therapeutics Drugs Sales Price (K USD/Unit)
Table 2016 Global Urological Cancer Therapeutics Drugs Sales Price (K USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (Units) of Urological Cancer Therapeutics Drugs 2012-2017E
Figure North America 2012-2017E Urological Cancer Therapeutics Drugs Sales Price (K USD/Unit)
Figure North America 2016 Urological Cancer Therapeutics Drugs Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (Units) of Urological Cancer Therapeutics Drugs 2012-2017E
Figure China 2012-2017E Urological Cancer Therapeutics Drugs Sales Price (K USD/Unit)
Figure China 2016 Urological Cancer Therapeutics Drugs Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (Units) of Urological Cancer Therapeutics Drugs 2012-2017E
Figure Europe 2012-2017E Urological Cancer Therapeutics Drugs Sales Price (K USD/Unit)
Figure Europe 2016 Urological Cancer Therapeutics Drugs Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (Units) of Urological Cancer Therapeutics Drugs 2012-2017E
Figure Southeast Asia 2012-2017E Urological Cancer Therapeutics Drugs Sales Price (K USD/Unit)
Figure Southeast Asia 2016 Urological Cancer Therapeutics Drugs Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (Units) of Urological Cancer Therapeutics Drugs 2012-2017E
Figure Japan 2012-2017E Urological Cancer Therapeutics Drugs Sales Price (K USD/Unit)
Figure Japan 2016 Urological Cancer Therapeutics Drugs Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (Units) of Urological Cancer Therapeutics Drugs 2012-2017E
Figure India 2012-2017E Urological Cancer Therapeutics Drugs Sales Price (K USD/Unit)
Figure India 2016 Urological Cancer Therapeutics Drugs Sales Market Share
Table Global 2012-2017E Urological Cancer Therapeutics Drugs Sales (Units) by Type
Table Different Types Urological Cancer Therapeutics Drugs Product Interview Price
Table Global 2012-2017E Urological Cancer Therapeutics Drugs Sales (Units) by Application
Table Different Application Urological Cancer Therapeutics Drugs Product Interview Price
Table Novartis Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novartis Urological Cancer Therapeutics Drugs Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure 2016 Novartis Urological Cancer Therapeutics Drugs Business Region Distribution
Table Pfizer Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pfizer Urological Cancer Therapeutics Drugs Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure 2016 Pfizer Urological Cancer Therapeutics Drugs Business Region Distribution
Table Johnson & Johnson Information List
Table Product A Overview
Table Product B Overview
Table 2015 Johnson & Johnson Urological Cancer Therapeutics Drugs Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure 2016 Johnson & Johnson Urological Cancer Therapeutics Drugs Business Region Distribution
Table AstraZeneca Information List
Table Product A Overview
Table Product B Overview
Table 2016 AstraZeneca Urological Cancer Therapeutics Drugs Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure 2016 AstraZeneca Urological Cancer Therapeutics Drugs Business Region Distribution
Table Astellas Information List
Table Product A Overview
Table Product B Overview
Table 2016 Astellas Urological Cancer Therapeutics Drugs Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure 2016 Astellas Urological Cancer Therapeutics Drugs Business Region Distribution
Table Bristol-Myers Squibb Information List
Table Product A Overview
Table Product B Overview
Table 2016 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure 2016 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Business Region Distribution
Table Abbott Laboratories Information List
Table Product A Overview
Table Product B Overview
Table 2016 Abbott Laboratories Urological Cancer Therapeutics Drugs Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure 2016 Abbott Laboratories Urological Cancer Therapeutics Drugs Business Region Distribution
Table Celgene Corporation Information List
Table Product A Overview
Table Product B Overview
Table 2016 Celgene Corporation Urological Cancer Therapeutics Drugs Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure 2016 Celgene Corporation Urological Cancer Therapeutics Drugs Business Region Distribution
Table Dendreon Corporation Information List
Table Product A Overview
Table Product B Overview
Table 2016 Dendreon Corporation Urological Cancer Therapeutics Drugs Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure 2016 Dendreon Corporation Urological Cancer Therapeutics Drugs Business Region Distribution
Table Ferring Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure 2016 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Business Region Distribution
Table GlaxoSmithKline plc Information List
Table Indevus Pharmaceuticals Inc Information List
Table Ipsen Information List
Table Roche Healthcare Information List
Table Sanofi S.A. Information List
Figure Global 2017-2022 Urological Cancer Therapeutics Drugs Market Size (Units) and Growth Rate Forecast
Figure Global 2017-2022 Urological Cancer Therapeutics Drugs Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Urological Cancer Therapeutics Drugs Sales Price (K USD/Unit) Forecast
Figure North America 2017-2022 Urological Cancer Therapeutics Drugs Consumption Volume (Units) and Growth Rate Forecast
Figure China 2017-2022 Urological Cancer Therapeutics Drugs Consumption Volume (Units) and Growth Rate Forecast
Figure Europe 2017-2022 Urological Cancer Therapeutics Drugs Consumption Volume (Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Urological Cancer Therapeutics Drugs Consumption Volume (Units) and Growth Rate Forecast
Figure Japan 2017-2022 Urological Cancer Therapeutics Drugs Consumption Volume (Units) and Growth Rate Forecast
Figure India 2017-2022 Urological Cancer Therapeutics Drugs Consumption Volume (Units) and Growth Rate Forecast
Table Global Sales Volume (Units) of Urological Cancer Therapeutics Drugs by Type 2017-2022
Table Global Consumption Volume (Units) of Urological Cancer Therapeutics Drugs by Application 2017-2022
Table Traders or Distributors with Contact Information of Urological Cancer Therapeutics Drugs by Region